drugset / Trial / NCT00354562
A Phase 2 Study Evaluating ABT-751 in Combination With Taxotere in Advanced Non-Small Cell Lung Cancer
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To determine the efficacy of ABT-751 when administered in combination with standard docetaxel in subjects with advanced or metastatic NSCLC.
Timeline
- Start
- 2007-02
- Primary completion
- 2008-02
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | ABT-751 | Other / unclassified | 200 mg | — |
| Comparator | Docetaxel | Small molecule | — | — |